Bollag Gideon - Plexxikon Inc | 人才画像

基本信息

浏览量：23

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 271 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

OPN-6602, an Orally Bioavailable EP300/CBP Bromodomain Inhibitor, Targets Multiple Myeloma Through Suppression of IRF4 and MYC

Bernice Matusow, Sadegh Saghafinia, Pei, Amanda Kohler, Pan-Yu Chen, Christine Nichols,Parmveer Singh,Kerry Inokuchi,Jackie M. Walling,Gideon Bollag

BLOOD (2024): 1908-1909

引用0浏览0引用

Targeting TAZ-TEAD in Minimal Residual Disease Enhances the Duration of Targeted Therapy in Melanoma Models

Connor A. Ott,Timothy Purwin,Manoela Tiago, Kristine Lou, Pan-Yu Chen, Somaneth Chowdhury, Glenn Mersky,Nir Hacohen,John Lamar,Claudia Capparelli,Gideon Bollag,Andrew Aplin

CANCER RESEARCHno. 6 (2024)

引用0浏览0引用

OPN-6602, a Potent Dual EP300/CBP Bromodomain Inhibitor, Targets Multiple Myeloma Through Concomitant Suppression of IRF4 and C-Myc

Bernice Matusow,Wayne Spevak,Chao Zhang,Yan Ma,Rafe Shellooe,James Tsai, Pei, Pan Yu Chen,Gaston Habets, Christine Nichols,Parmveer Singh,Kerry Inokuchi,Jackie Walling,Jason Halladay,Gideon Bollag

Cancer Researchno. 6_Supplement (2024): 660-660

引用0浏览0引用

BET Inhibition As a Targeted Epigenetic Approach to Reverse T Cell Dysfunction in Chronic Lymphocytic Leukemia

Audrey L. Smith,Alexandria P. Eiken,Sydney A. Skupa,Christopher R. D'Angelo,Avyakta Kallam,Matthew A. Lunning,Gregory Bociek,Julie M. Vose,Ben Powell,Gideon Bollag Dalia

JCI Insight（2024）

引用0浏览0WOS引用

A Phase 1b, Dose Escalation/Dose Expansion, Multicenter, Open-Label Study to Assess the Safety and Tolerability of OPN-6602 Monotherapy and in Combination with Dexamethasone in Subjects with Relapsed And/or Refractory Multiple Myeloma

Jackie M. Walling,Bernice Matusow, Christine Nichols,Parmveer Singh,Kerry Inokuchi,Gideon Bollag

BLOOD（2024）

引用0浏览0引用

RAF inhibitors activate the integrated stress response by direct activation of GCN2

Rebecca Gilley,Andrew M Kidger,Graham Neill,Paul Severson,Dominic P Byrne,Niall S Kenneth,Gideon Bollag, Chao Zhang,Taiana M de Oliveira,Patrick Eyers,Richard Bayliss,Glenn R Masson,Simon J Cook

biorxiv（2024）

引用0浏览0引用

OPN-9840, a Non-Covalent Potent Pan-Tead Inhibitor, Exhibits Single Agent Efficacy in Preclinical Malignant Mesothelioma Models

Pan-Yu Chen,Bernice Matusow,James Tsai, Peipei Li,Hoa Nguyen,Gaston Habets,Gideon Bollag, Somenath Chowdhury

Cancer Researchno. 6_Supplement (2024): 7264-7264

引用1浏览0引用

Supplementary Figure 4 from CSF1R Signaling Blockade Stanches Tumor-Infiltrating Myeloid Cells and Improves the Efficacy of Radiotherapy in Prostate Cancer

Jingying Xu,Jemima Escamilla,Stephen Mok,John David,Saul Priceman,Brian West,Gideon Bollag,William McBride,Lily Wu

openalex（2023）

引用0浏览0引用

Supplemental Info from Response and Resistance to Paradox-Breaking BRAF Inhibitor in Melanomas in Vivo and Ex Vivo

Edward J. Hartsough,Curtis H. Kugel,Michael J. Vido,Adam C. Berger,Timothy J. Purwin,Allison Goldberg,Michael A. Davies,Matthew J. Schiewer,Karen E. Knudsen,Gideon Bollag,Andrew E. Aplin

openalex（2023）

引用0浏览0引用

Supplementary Figure 2 from CSF1R Signaling Blockade Stanches Tumor-Infiltrating Myeloid Cells and Improves the Efficacy of Radiotherapy in Prostate Cancer

Jingying Xu,Jemima Escamilla,Stephen Mok,John David,Saul Priceman,Brian West,Gideon Bollag,William McBride,Lily Wu

openalex（2023）

引用0浏览0引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn